Pfizer, Flynn Pharma lodge fresh appeals of UK fines for ‘excessive’ drug pricing
Pfizer and Flynn Pharma today freshly appealed fines of tens of millions of pounds levied by the UK competition regulator for abusing dominant positions through overcharging for epilepsy drugs. More than...To view the full article, register now.
Already a subscriber? Click here to view full article